Stem Cell Therapy for Disease, Injury, and Ageing
Our state-of-the-art medical facility provides patients with access to breakthrough stem cell treatments for degenerative disease, injury, and longevity. All of our SC21 treatment programs are based on the core elements of early passage Mesenchymal Stem Cells (MSCs) and MSC Extracellular Vesicles (EVs), which are exclusively produced at our FDA registered Bio-Pharma laboratories.
Alongside the core elements of SC21 treatment programs – cellular medicine – each patient will undergo a personalised supportive therapy plan designed to target the specifics of their condition or treatment focus.